Molecular Epidemiological Analysis of Escherichia coli Sequence Type ST131 (O25:H4) andblaCTX-M-15among Extended-Spectrum-β-Lactamase-Producing E. coli from the United States, 2000 to 2009

Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance

(2012) Johann D. D. Pitout   Frontiers in Microbiology

Escherichia coliSequence Type ST131 as the Major Cause of Serious Multidrug‐ResistantE. coliInfections in the United States

(2010) James R. Johnson et al.   CLINICAL INFECTIOUS DISEASES

Identification of CTX-M β-lactamases in Escherichia coli from hospitalized patients and residents of long-term care facilities

(2010) Carl Urban et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals

(2010) Gisele Peirano et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4

(2010) Gisele Peirano et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain

(2010) B. A. Rogers et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

WITHIN-HOUSEHOLD SHARING OF A FLUOROQUINOLONE-RESISTANT ESCHERICHIA COLI SEQUENCE TYPE ST131 STRAIN CAUSING PEDIATRIC OSTEOARTICULAR INFECTION

(2010) James R. Johnson et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Molecular Epidemiology of CTX-M-Producing Escherichia coli Isolates at a Tertiary Medical Center in Western Pennsylvania

(2009) H. E. Sidjabat et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Epidemic Clonal Groups of Escherichia coli as a Cause of Antimicrobial-Resistant Urinary Tract Infections in Canada, 2002 to 2004

(2009) J. R. Johnson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Escherichia coli Sequence Type ST131 as an Emerging Fluoroquinolone-Resistant Uropathogen among Renal Transplant Recipients

(2009) J. R. Johnson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Escherichia coliPyomyositis: An Emerging Infectious Disease among Patients with Hematologic Malignancies

(2009) Karen J. Vigil et al.   CLINICAL INFECTIOUS DISEASES

Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains

(2009) O. Clermont et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Sharing of Escherichia coli Sequence Type ST131 and Other Multidrug-Resistant and Urovirulent E. coli Strains among Dogs and Cats within a Household

(2009) J. R. Johnson et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Prevalence of CTX-M  -Lactamases in Philadelphia, Pennsylvania

(2009) S. E. McGettigan et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Transmission of an Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli (Sequence Type ST131) Strain between a Father and Daughter Resulting in Septic Shock and Emphysematous Pyelonephritis

(2009) P. T. Ender et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Emergence of Fluoroquinolone Resistance in Outpatient Urinary Escherichia coli Isolates

(2008) Luke Johnson et al.   AMERICAN JOURNAL OF MEDICINE

The CTX-M-15-producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup

(2008) Olivier Clermont et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY